Advertisement

Vi-Jon, Inc. Company Profile

05:31 EDT 23rd May 2013 | BioPortfolio

Founded in 1908, Vi-Jon is one of the nation’s largest private brand HBC (Health & Beauty Care) manufacturers. It also produces the Germ-X® brand hand sanitizers. Headquartered in St. Louis, the company operates five manufacturing and distribution facilities in Missouri and Tennessee, supplying mass market retailers, drug store chains, supermarkets and convenience stores throughout North America. For information, visit: www.vijon.com.


News Articles [375627 Results]

Oral Contraceptives and Cancer Risk: Questions and Answers

A fact sheet about research on the risk of developing cancer of the breast, cervix, liver, and ovary from the use of oral contraceptives.

Meet the Experts: Discussion About IPOs in the Biotech Industry

Fintan Walton, CEO PharmaVentures, leads this month's international panel in a discussion about IPOs in the biotech industry, drawing on the wide-ranging experiences of our experts to address the prac...

ZymoGenetics: 25 Years Young: An Interview with Bruce Carter, President and CEO

Fintan Walton, CEO of PharmaVentures, talks exclusively to Bruce Carter, President and CEO of ZymoGenetics, a company that celebrated its 25th anniversary on 22 June 2006. Bruce discusses a number of...

Meet the Experts: Discussion About Deal Valuation

This month, Fintan Walton leads our expert panel in a discussion about deal valuation, further exploring the risks and benefits associated with the different methodologies outlined in the business rep...

Meet the Experts: Discussion on Deal Making in Oncology

Fintan Walton leads this month's expert panel discussion on the topic of oncology deal making. The panel explores the issues facing big pharma and small biotech and the alliance strategies they employ...

Meet the Experts: Discussion on Early-Stage Financing of Biotech Companies in Europe

Fintan Walton leads our panel of industry experts in an in-depth discussion about the early-stage financing of biotech companies in Europe. With viewpoints from both financial and biotech companies, o...

Simcere Pharmaceuticals: Dr H Ming Pang, Head of International Business

Dr Pang talks to Fintan Walton about biotechnology trends in China. He examines what the Chinese pharmaceutical and biotechnology industry has to offer the global market, discusses the opportunities i...

Galapagos: Onno van de Stolpe, CEO

Onno van de Stolpe talks to Fintan Walton, about Galapagos' current business model and overall strategic outlook. They discuss the integration of BioFocus following its acquisition by Galapagos in Nov...

Clinical Trials [66088 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [43912 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

Water Pik, Inc.

Water Pik is a leading developer, manufacturer and marketer of innovative personal healthcare products sold under the Waterpik® brand name. The Company has developed and introd...

More Information about "Vi-Jon, Inc." on BioPortfolio

We have published hundreds of Vi-Jon, Inc. news stories on BioPortfolio along with dozens of Vi-Jon, Inc. Clinical Trials and PubMed Articles about Vi-Jon, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vi-Jon, Inc. Companies in our database. You can also find out about relevant Vi-Jon, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement